Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMulberry Group Regulatory News (MUL)

Share Price Information for Mulberry Group (MUL)

Share Price is delayed by 15 minutes
Get Live Data
136.00    0.00 (0.00%)
Bid:
132.00
Ask:
140.00
Spread: 8.00 (6.061%)
Market Cap: £95.42m
MUL Live PriceLast checked at - London Stock Exchange

Intraday Mulberry Group Share Chart

Director's Dealing and Additional Listing

1 Aug 2013 17:30

RNS Number : 7844K
Mulberry Group PLC
01 August 2013
 



1 August 2013

 

Mulberry Group plc

 

Director's Dealing and Application for Admission of Ordinary Shares

 

Mulberry Group plc ("Mulberry" or the "Company") has been notified that Godfrey Davis, Non Executive Chairman, has exercised options over a total of 11,069 ordinary shares of 5 pence each in the Company (the "Ordinary Shares") as follows:

 

Scheme

Number of Options

Exercise Price

Mulberry Group plc Deferred Bonus Plan

11,069

nil cost

 

Under the terms of the Company's share option schemes, Godfrey Davis has agreed to receive cash (net of the exercise price of the relevant options) in lieu of Ordinary Shares, which will be satisfied through the issue and sale of 11,069 new Ordinary Shares by the Company. 7,922 of these new Ordinary Shares were conditionally placed on 31 July 2013 at a price of £9.68 per Ordinary Share and 3,147 of these new Ordinary Shares were conditionally placed today, 1 August 2013, at a price of £9.625.

 

Following this transaction, Godfrey Davis' beneficial interest in the Company consists of 718,527 Ordinary Shares representing 1.20% of the Company's issued Ordinary Shares. Godfrey Davis also holds vested rights over 300,000 Ordinary Shares under Mulberry's Co-Ownership Plan, 18,298 vested nil cost options under the Company's Deferred Bonus Plan and 90,000 options under the Company's 2008 Unapproved Share Option Scheme.

 

Pursuant to the exercise of options and issue and sale of new Ordinary Shares noted above, the Company has made an application to the London Stock Exchange for 11,069 new Ordinary Shares to be admitted to AIM. The new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares in issue. It is expected that admission of 7,922 new Ordinary Shares will take place on 7 August 2013 and that admission of 3,147 new Ordinary Shares will take place on 8 August 2013.

 

 

Enquiries:

 

Pelham Bell Pottinger

Dan de Belder / Lucy Miles

0207 861 3232

Altium

Ben Thorne / Katherine Hobbs

0207 484 4040

Barclays Capital

Jon Bathard-Smith

0207 623 2323

Mulberry Investor Relations

Amelia Fincher

 

0207 605 6771

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISEAKPFEFSDEFF
Date   Source Headline
4th Oct 202412:00 pmRNSForm 8.5 (EPT/RI) Mulberry Group PLC
4th Oct 202411:25 amRNSRule 2.9 Announcement
4th Oct 20247:00 amRNSShare subscription and Rule 9 dispensation
3rd Oct 20244:22 pmRNSUpdate on the Subscription
3rd Oct 202412:00 pmRNSForm 8.5 (EPT/RI) Mulberry Group PLC
2nd Oct 202412:00 pmRNSForm 8.5 (EPT/RI) Mulberry Group PLC
1st Oct 202412:00 pmRNSForm 8.5 (EPT/RI) Mulberry Group PLC
1st Oct 20247:00 amRNSChange of NOMAD
1st Oct 20247:00 amRNSRejection of possible offer from Frasers Group plc
30th Sep 202410:07 amRNSStatement on Possible Offer
30th Sep 20247:15 amRNSRetail Offer
30th Sep 20247:00 amRNSPublishing of Annual Report
27th Sep 20244:44 pmRNSPreliminary Results and Capital Raising
2nd Sep 20243:39 pmRNSDirector/PDMR Shareholding
2nd Aug 202410:38 amRNSGrant of Options
9th Jul 202411:30 amRNSDirectorate Change – Chief Executive Officer
1st May 20247:00 amRNSYear End Trading Update
6th Feb 20249:42 amRNSDirectors Dealing
22nd Jan 20247:00 amRNSAppointment of Corporate Broker
17th Jan 20247:00 amRNSTrading Update
30th Nov 20237:00 amRNSHalf Year Results
25th Sep 20235:19 pmRNSDirectors Dealing
7th Sep 20232:11 pmRNSResult of AGM
23rd Aug 20237:00 amRNSAppointment ofl Independent Non-Executive Director
4th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
19th Jul 20237:00 amRNSGrant under 2008 Unapproved Share Option Scheme
28th Jun 20237:00 amRNSPreliminary results
22nd Jun 20237:00 amRNSAudited FY23 Results - revised announcement date
20th Apr 20237:00 amRNSYear End Trading Update
30th Nov 20229:05 amRNSSecond Price Monitoring Extn
30th Nov 20229:00 amRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf Year Results
17th Nov 20224:41 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
7th Sep 202212:22 pmRNSAGM Statement
23rd Aug 20227:00 amRNSDirectorate Changes
3rd Aug 20229:11 amRNSAnnual Report and notice of General Meeting
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
6th Jul 20222:08 pmRNSReplacement: Director/PDMR Shareholding
5th Jul 20225:53 pmRNSDirector/PDMR Dealing
29th Jun 20227:00 amRNSFinal Results
29th Mar 20227:00 amRNSTrading Update and notice of Full Year Results
9th Mar 20222:01 pmRNSPrice Monitoring Extension
24th Nov 20217:00 amRNSHalf-year Report
8th Sep 20213:11 pmRNSResult of AGM
11th Aug 20215:09 pmRNSAnnual Financial Report and Notice of AGM
21st Jul 20217:00 amRNSAnnual Financial Report
6th Jul 20217:01 amRNSEarly exit of Paris lease
28th Apr 20217:00 amRNSTrading Update
20th Apr 20217:00 amRNSLaunch of New Sustainability Manifesto

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.